Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)

Bewersdorf, JP; Zeidan, AM

Zeidan, AM (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Sect Hematol, 333 Cedar St,POB 208028, New Haven, CT 06520 USA.

CANCERS, 2021; 13 (7):

Abstract

Simple Summary Myelodysplastic syndrome (MDS) and chronic myelomonocytic leukemia (CMML) are two blood cancers with variable symptoms of low blood cou......

Full Text Link